BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis
USA - NYSE:BRBR - US07831C1036 - Common Stock
34.5 USD
-0.22 (-0.63%)
34.5 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to BRBR. BRBR was compared to 36 industry peers in the Personal Care Products industry. While BRBR has a great profitability rating, there are some minor concerns on its financial health. BRBR has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
BRBR had positive earnings in the past year.
In the past year BRBR had a positive cash flow from operations.
Each year in the past 5 years BRBR has been profitable.
Each year in the past 5 years BRBR had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 22.97%, BRBR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 39.15%, BRBR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 12.77%.
The last Return On Invested Capital (39.15%) for BRBR is above the 3 year average (38.65%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.97% | ||
| ROE | N/A | ||
| ROIC | 39.15% |
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
1.3 Margins
BRBR's Profit Margin of 10.26% is amongst the best of the industry. BRBR outperforms 88.89% of its industry peers.
BRBR's Profit Margin has declined in the last couple of years.
The Operating Margin of BRBR (16.51%) is better than 83.33% of its industry peers.
In the last couple of years the Operating Margin of BRBR has remained more or less at the same level.
With a Gross Margin value of 35.43%, BRBR is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BRBR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 16.51% | ||
| PM (TTM) | 10.26% | ||
| GM | 35.43% |
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BRBR is creating value.
BRBR has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BRBR has been increased compared to 5 years ago.
BRBR has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 6.31 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR has a Altman-Z score of 6.31. This is amongst the best in the industry. BRBR outperforms 88.89% of its industry peers.
BRBR has a debt to FCF ratio of 7.96. This is a slightly negative value and a sign of low solvency as BRBR would need 7.96 years to pay back of all of its debts.
BRBR has a better Debt to FCF ratio (7.96) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.96 | ||
| Altman-Z | 6.31 |
ROIC/WACC4.82
WACC8.12%
2.3 Liquidity
BRBR has a Current Ratio of 2.55. This indicates that BRBR is financially healthy and has no problem in meeting its short term obligations.
BRBR has a Current ratio of 2.55. This is in the better half of the industry: BRBR outperforms 63.89% of its industry peers.
BRBR has a Quick Ratio of 1.12. This is a normal value and indicates that BRBR is financially healthy and should not expect problems in meeting its short term obligations.
BRBR has a Quick ratio (1.12) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.55 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 18.58% over the past year.
The earnings per share for BRBR have been decreasing by -12.29% on average. This is quite bad
Looking at the last year, BRBR shows a quite strong growth in Revenue. The Revenue has grown by 16.27% in the last year.
The Revenue has been growing by 18.50% on average over the past years. This is quite good.
EPS 1Y (TTM)18.58%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%1.85%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%6.23%
3.2 Future
The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
The Revenue is expected to grow by 8.27% on average over the next years. This is quite good.
EPS Next Y16.72%
EPS Next 2Y11.3%
EPS Next 3Y11.95%
EPS Next 5Y10.38%
Revenue Next Year15.95%
Revenue Next 2Y12.83%
Revenue Next 3Y11.51%
Revenue Next 5Y8.27%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
BRBR is valuated correctly with a Price/Earnings ratio of 15.90.
Based on the Price/Earnings ratio, BRBR is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
BRBR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.55, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.43, BRBR is valued correctly.
BRBR's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BRBR is cheaper than 75.00% of the companies in the same industry.
BRBR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.9 | ||
| Fwd PE | 14.43 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BRBR is valued a bit cheaper than the industry average as 61.11% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as BRBR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.3 | ||
| EV/EBITDA | 13.84 |
4.3 Compensation for Growth
BRBR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BRBR has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.95
PEG (5Y)N/A
EPS Next 2Y11.3%
EPS Next 3Y11.95%
5. Dividend
5.1 Amount
BRBR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
34.5
-0.22 (-0.63%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners102.81%
Inst Owner Change0.1%
Ins Owners1.3%
Ins Owner Change-0.08%
Market Cap4.35B
Analysts83.64
Price Target57.32 (66.14%)
Short Float %4.95%
Short Ratio1.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.74%
Min EPS beat(2)-0.84%
Max EPS beat(2)8.31%
EPS beat(4)3
Avg EPS beat(4)6.72%
Min EPS beat(4)-0.84%
Max EPS beat(4)18.96%
EPS beat(8)7
Avg EPS beat(8)11.06%
EPS beat(12)11
Avg EPS beat(12)10.83%
EPS beat(16)14
Avg EPS beat(16)11.54%
Revenue beat(2)1
Avg Revenue beat(2)0.35%
Min Revenue beat(2)-0.33%
Max Revenue beat(2)1.03%
Revenue beat(4)2
Avg Revenue beat(4)0.46%
Min Revenue beat(4)-0.52%
Max Revenue beat(4)1.64%
Revenue beat(8)5
Avg Revenue beat(8)1.26%
Revenue beat(12)7
Avg Revenue beat(12)0.65%
Revenue beat(16)8
Avg Revenue beat(16)-0.21%
PT rev (1m)-0.12%
PT rev (3m)-28.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-8.51%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)0.42%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-2.48%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 15.9 | ||
| Fwd PE | 14.43 | ||
| P/S | 1.95 | ||
| P/FCF | 34.3 | ||
| P/OCF | 33.03 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.84 |
EPS(TTM)2.17
EY6.29%
EPS(NY)2.39
Fwd EY6.93%
FCF(TTM)1.01
FCFY2.92%
OCF(TTM)1.04
OCFY3.03%
SpS17.66
BVpS-2.46
TBVpS-4.01
PEG (NY)0.95
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.97% | ||
| ROE | N/A | ||
| ROCE | 52.23% | ||
| ROIC | 39.15% | ||
| ROICexc | 41.74% | ||
| ROICexgc | 59.28% | ||
| OM | 16.51% | ||
| PM (TTM) | 10.26% | ||
| GM | 35.43% | ||
| FCFM | 5.7% |
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score5
Asset Turnover2.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.96 | ||
| Debt/EBITDA | 2.62 | ||
| Cap/Depr | 26.49% | ||
| Cap/Sales | 0.22% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 34.11% | ||
| Profit Quality | 55.5% | ||
| Current Ratio | 2.55 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 6.31 |
F-Score5
WACC8.12%
ROIC/WACC4.82
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)18.58%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%1.85%
EPS Next Y16.72%
EPS Next 2Y11.3%
EPS Next 3Y11.95%
EPS Next 5Y10.38%
Revenue 1Y (TTM)16.27%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%6.23%
Revenue Next Year15.95%
Revenue Next 2Y12.83%
Revenue Next 3Y11.51%
Revenue Next 5Y8.27%
EBIT growth 1Y3.85%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year23.45%
EBIT Next 3Y12.4%
EBIT Next 5Y9.52%
FCF growth 1Y-8.65%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y-6.2%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%